Apidra is a brand of insulin glulisine, a fast-acting insulin analog used to treat diabetes mellitus. It is used to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes. Apidra is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat endocrine and metabolic disorders such as diabetes, thyroid disorders, and obesity. These drugs are used to regulate hormones, metabolism, and other body functions. The Endocrine and Metabolic Disorders Drugs market is a rapidly growing market, driven by the increasing prevalence of diabetes and other endocrine and metabolic disorders. The market is expected to continue to grow in the coming years, driven by the increasing demand for new and improved treatments. Some of the major companies in the Apidra market include Sanofi, Eli Lilly, Novo Nordisk, Merck, and AstraZeneca. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
